Member Investor Portfolio Report
Q2 2024 Member Investor Portfolio Report
New investors from outside Ohio continued to invest in innovative technologies throughout the state. This report also highlights 19 life science companies for their milestone achievements including fundraising, FDA approvals, clinical study completion, and business development expansion.
Q1 2024 Member Investor Portfolio Report
Despite economic challenges, out-of-state investment drove significant growth in Ohio’s life sciences sector in Q1 2024, with $271 million raised across 26 companies, notably in medical devices, therapeutics, and healthcare software. This first-of-its-kind report highlights the success and opportunity in Ohio’s rapidly growing life sciences sector.